Sam Regan

@MROQC1 @mdsquared44

This new #advancesRO article from Regan et al was presented at #ASTRO24's Poster Q&A Session 08. Read their article "Microboost in Localized Prostate Cancer: Analysis of a Statewide Quality Consortium" here: tinyurl.com/reganam24

Our chief resident @SamReganMD taking the stage at #ASTRO24 to discuss @UMichRadOnc head and neck group's work exploring ctDNA in HPV+ head and neck cancer.

Samuel Regan, MD, and Benjamin Rosen, PhD, on De-escalating Radiotherapy for HPV-Related Oropharyngeal Cancer ascopost.com/videos/2024-mu… #hncsm #oropharyngealcancer #oncology #HNCS24 @UMich @SamReganMD

“We plan to continue to investigate the role of multimodal approaches for de-escalation of therapy for this patient population,” said Samuel Regan, MD. #hncsm #HNCS24 | @ASTRO_org @SamReganMD cancernetwork.com/view/chemoradi…

Our HNCa rad onc team's innovative work demonstrates enhanced patient quality of life with reduced chemo radiation in HPV+ oropharynx ca, all while ensuring tumor control! Kudos to @MierzwaMichelle @SamReganMD and team! @UMRogelCancer @umichmedicine michiganmedicine.org/health-lab/les…

Congrats to two of our residents, Michael Dykstra and Sam Regan, for winning Conquer Cancer Merit Awards for their ASCO GU symposium abstracts! Both will be presenting work done with @MROQC1. conquer.org/news/conquer-c… @mdsquared44 @SamReganMD @UMichRadOnc @UMichMedSchool

#PROSPECT Diving into the acute patient-reported outcomes CRT⬆️diarrhea FOLFOX significantly higher rates of severe: 🔴Anxiety 🔴Depression 🔴Appetite 🔴Constipation 🔴Dysphagia 🔴Dyspnea 🔴Edema 🔴Fatigue 🔴Mucositis 🔴Nausea 🔴Vomiting 🔴Neuropathy 🤔 @PrajnanDasMD

Congrats to our newly matched residents! We are so happy to have you joining the @UMichRadOnc family! Can’t wait to work with you all!

Delighted to welcome our newly matched residents to the Michigan family! Congratulations! 🎉 @UMichRadOnc

Resident Tiki Party! 🏖️🏝️☀️🧉

Happy Halloween from University of Michigan Department of Radiation Oncology! The most caring animals you will find anywhere. 👻🎃🎃👻 Wishing everyone a safe Halloween! @UMRogelCancer @umichmedicine @ASTRO_org @ASCO

Delighted to present updated data from the PACIFIC trial in unresectable Stage III NSCLC @myESMO Durable benefit with durvalumab @4 years - almost 50% of patients alive - MS reached for the first time and is an unprecedented 47.5 months =major benefit for patients @MCRCnews

Today’s update on randomized trials investigating the life-prolonging value of SBRT for people with stage IV lung cancer. #ASCO20 #lcsm #radonc